The patent covers a vaccine-making process that targets the most vulnerable point in a coronavirus’ structure, representing a key step for any new vaccine.
Continue reading
E-Patient Health Care Reporter
Collection of Eclectic Medical, Spiritual and Lifestyle Wisdom Since 2009
